Cytoreductive single-fraction stereotactic radiation therapy prior to living donor transplantation for inoperable liver-confined metastatic rectal cancer.
作者信息
Papanikolaou Panos A, Wesson Russell N, Azad Nilofer S, Meyer Jeffrey J
机构信息
Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
出版信息
J Radiosurg SBRT. 2024;9(2):181-183.
Abstract
摘要
相似文献
1
2
Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".立体定向体部放疗（SBRT）治疗医学上无法手术切除的肺转移瘤——德国“立体定向放疗”工作组的汇总分析
Lung Cancer. 2016 Jul;97:51-8. doi: 10.1016/j.lungcan.2016.04.012. Epub 2016 Apr 26.
3
Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation.立体定向体部放疗治疗肝癌作为移植桥接的长期结果。
Liver Transpl. 2012 Aug;18(8):949-54. doi: 10.1002/lt.23439.
4
Stereotactic Body Radiotherapy for Inoperable Liver Tumors: Results of a Single Institutional Experience.立体定向体部放射治疗不可切除性肝肿瘤：单机构经验结果
Cureus. 2016 Dec 20;8(12):e935. doi: 10.7759/cureus.935.
5
Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma.立体定向体部放射治疗（SBRT）在不可切除的早期肝癌中作为确定性治疗和肝移植桥接。
Radiat Oncol. 2017 Oct 19;12(1):163. doi: 10.1186/s13014-017-0899-4.
6
Image-Guided Stereotactic Body Radiotherapy (SBRT) with Enhanced Visualization of Tumor and Hepatic Parenchyma in Patients with Primary and Metastatic Liver Malignancies.原发性和转移性肝脏恶性肿瘤患者的图像引导立体定向体部放疗（SBRT）与肿瘤及肝实质的强化可视化
Cancers (Basel). 2025 Mar 25;17(7):1088. doi: 10.3390/cancers17071088.
7
Stereotactic body radiation therapy for colorectal cancer liver metastases.立体定向体部放射治疗用于结直肠癌肝转移
J Gastrointest Oncol. 2024 Aug 31;15(4):1917-1925. doi: 10.21037/jgo-22-1183. Epub 2023 Jun 29.
8
Lobar Gross Endobronchial Disease Predicts for Overall Survival and Grade 5 Pulmonary Toxicity in Medically Inoperable Early Stage Non-Small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy.叶段支气管内大病灶疾病可预测接受立体定向体部放射治疗的医学上无法手术的早期非小细胞肺癌患者的总生存期和5级肺部毒性。
Front Oncol. 2021 Nov 29;11:728519. doi: 10.3389/fonc.2021.728519. eCollection 2021.
9
Stereotactic Body Radiation Therapy for Liver Tumors: Current Status and Perspectives.肝脏肿瘤的立体定向体部放射治疗：现状与展望
Anticancer Res. 2018 Feb;38(2):591-599. doi: 10.21873/anticanres.12263.
10
Definitive results of a prospective non-randomized phase 2 study on stereotactic body radiation therapy (sbrt) for medically inoperable lung and liver oligometastases from breast cancer.一项针对乳腺癌无法手术的肺和肝寡转移的立体定向体部放疗（SBRT）前瞻性非随机 2 期研究的明确结果。
Radiother Oncol. 2024 Jun;195:110240. doi: 10.1016/j.radonc.2024.110240. Epub 2024 Mar 22.
本文引用的文献
1
Long-Term Survival, Prognostic Factors, and Selection of Patients With Colorectal Cancer for Liver Transplant: A Nonrandomized Controlled Trial.结直肠癌患者肝移植的长期生存、预后因素及患者选择：一项非随机对照试验。
JAMA Surg. 2023 Sep 1;158(9):e232932. doi: 10.1001/jamasurg.2023.2932. Epub 2023 Sep 13.
2
Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines.不可切除结直肠肝转移的肝移植：国际肝胆胰协会共识指南。
Lancet Gastroenterol Hepatol. 2021 Nov;6(11):933-946. doi: 10.1016/S2468-1253(21)00219-3. Epub 2021 Sep 8.
3
Prospective Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma on Waitlist for Liver Transplant.等待肝移植的肝细胞癌患者立体定向体部放射治疗的前瞻性研究。
Hepatology. 2021 Nov;74(5):2580-2594. doi: 10.1002/hep.31992. Epub 2021 Sep 30.
4
Outcomes After Stereotactic Body Radiation Therapy as a Bridging Modality to Liver Transplantation for Hepatocellular Carcinoma.立体定向体部放疗作为肝细胞癌肝移植桥接治疗方式后的疗效
Adv Radiat Oncol. 2020 Sep 14;6(1):100559. doi: 10.1016/j.adro.2020.08.016. eCollection 2021 Jan-Feb.
5
Long-Term Results of a Phase 1 Dose-Escalation Trial and Subsequent Institutional Experience of Single-Fraction Stereotactic Ablative Radiation Therapy for Liver Metastases.单剂量立体定向消融放疗治疗肝转移瘤的 1 期剂量递增试验的长期结果和后续机构经验。
Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1387-1395. doi: 10.1016/j.ijrobp.2020.12.012. Epub 2020 Dec 16.
6
Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to oxaliplatin combination chemotherapy: implications for tumor marker monitoring and guidelines.接受奥沙利铂联合化疗的转移性结直肠癌患者癌胚抗原激增：对肿瘤标志物监测及指南的启示
J Clin Oncol. 2003 Dec 1;21(23):4466-7. doi: 10.1200/JCO.2003.99.200.
Zotero 插件